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Research on the development of intracranial an-eurysms has been performed in numerous fields such as hemodynamics,18 biomechanics,4 histol-
ogy,6 and computational fluid dynamics.21 Although these 
studies have provided new information regarding factors 
involved in aneurysm development, the results cannot be 
directly related to the growth rates of aneurysms. Given 
that an aneurysm’s size is a main determinant in its risk 
of rupture,26 lesion growth rates are a key factor in the re-
lation among aneurysm prevalence, the risk of aneurysm 
rupture, and the observed incidence of SAH. Although 
aneurysm growth has been suggested to be erratic,12 ex-
isting models of aneurysm screening or treatment gen-
erally incorporate a constant time-independent growth 
rate and risk of rupture. Aneurysms that grow fast in a 
short period of time14–16,30,31 are likely to have high risks 
of rupture for short periods of time.11 Variable growth 
rates with corresponding time-variable risks of rupture 
will change predictions of the SAH risk over different 
time intervals. Evidence regarding the actual growth pro-
cess may support or challenge current assumptions and 
perhaps evoke new screening and/or treatment strategies 
for unruptured aneurysms.24,33
Limited empirical data exist on the change in, or the 
consistency of, aneurysm growth rates over time. Exten-
sive data collection on growth rates is not feasible, be-
cause it would require frequent screening—for example, 
with MR angiography—of large groups of healthy indi-
viduals and persons with unruptured aneurysms. Thus, 
insight into aneurysm growth rates can be attained only 
by modeling the effects of different growth rates on an-
eurysms sizes and SAH incidence and comparing these 
results with the observed incidence of SAH in an ac- 
tual population. We constructed a model suitable for 
the simulation of individual patient histories. Drawing 
from a parametric distribution, aneurysm growth rates 
were assigned to individuals. As aneurysm formation and 
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Object. The annual rate of rupture of intracranial aneurysms is often assumed to be constant, but it is unknown 
whether this assumption is true. Recent case reports have suggested that aneurysms grow fast in a short period of 
time. The authors of the present report investigated the plausibility of a constant growth rate for intracranial aneu-
rysms.
Methods. Assuming a constant aneurysm growth rate within an individual and varying rates between individu-
als, a hypothetical cohort was simulated. Individuals with high growth rates will display aneurysm formation and rup-
ture at a young age; such persons disappear early from the hypothetical cohort. As a result the mean lesion growth rate 
varies over time. In hypothetical cohorts with different initial mean growth rates, the authors calculated age-specific 
incidence rates (per 100,000 person-years) of subarachnoid hemorrhage and compared these rates with population-
based data on the incidence of subarachnoid hemorrhage (per 100,000 person-years).
Results. A hypothetical cohort with a mean initial growth rate of 0.18 mm/year reproduced most closely the inci-
dence rates observed in the population. However, even for this most plausible hypothetical cohort, age-specific inci-
dence rates in the model differed substantially and statistically significantly from those observed in the population.
Conclusions. Based on the results of this study, it is unlikely that intracranial aneurysms in general grow at a 
constant time-independent rate. The authors hypothesized that the actual growth process is irregular and discontinu-
ous, which results in periods with and without aneurysm growth and with high and low risks of rupture. 
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rup ture occur at a young age in people with high lesion 
growth rates, such persons disappear early from a hypo-
thetical cohort; therefore, the mean lesion growth rate in 
cohorts decreases with time. We compared age-specific 
SAH incidence rates (per 100,000 person-years) in simu-
lated cohorts with various initial mean lesion growth rates 
with the rates observed in the general population, and we 
determined whether a constant intracranial aneurysm 
growth rate could lead to the SAH incidence observed in 
the actual population.
Methods
Here, we provide a textual description of the con-
structed model; a more detailed and mathematical de-
scription of the model is given in the Appendix. During 
the selection of relevant data from the literature, we placed 
emphasis on the general applicability of data. Because 
calculations of aneurysm prevalence and rupture risk 
vary widely among studies and populations,8,20 we col-
lected estimates from either systematic reviews or mul-
tinational studies whenever available. The calculation of 
incidence rates, IDRs, and corresponding CIs was based 
on the number of actual SAH incidents and the number of 
person-years in which these incidents occurred.7
Study Model
The model defined to measure the effect of assump-
tions on lesion growth rates is defined as a Markov mod-
el.22 The most relevant parameters of this model are given 
in Table 1. By definition, Markov models presume that an 
individual is in 1 of a finite number of predefined health 
states. All relevant events, such as rupture of an aneurysm 
or death from an unrelated event, are represented as tran-
sitions from one health state to another. The probabilities 
associated with these transitions typically depend on the 
characteristics of the individual under consideration. The 
term “(micro)simulation” refers to tracking the separate 
histories of individuals through the model in discrete 
time steps (cycles). In a dynamic simulation the charac-
teristics of individuals not only determine the transition 
probabilities, but also are permitted to change over time, 
that is, during the simulation. We constructed a dynamic 
simulation Markov model in which patient age and aneu-
rysm size changed over time. Note that because aneurysm 
growth rates are constant within an individual but vary 
between people, the risk of SAH increases differently 
over time for each person.
During each time cycle in the model, individuals 
might have died of causes other than SAH, aneurysms 
might have ruptured, or patients might have survived 
without experiencing SAH. Moreover, during each cycle 
an aneurysm grew according to a specific growth rate. 
Based on estimates in Table 1, the annual risk of SAH was 
derived from a continuous function relating aneurysm di-
ameter and location to the risk of rupture. This function 
is depicted in Fig. 1 (for details see Appendix). As a re-
sult of SAH or subsequent treatment, an individual might 
have survived and the aneurysm obliterated by treatment 
or the patient might have died. Additional simplifying as-
sumptions made with respect to the Markov model are 
described in Table 2.
The Scenarios
Each simulated cohort in the model comprised 50,000 
individuals, with an equal number of men and women. All 
individuals harbored 1 aneurysm with an initial diameter 
of 0 mm. Accordingly, patient age at the start of the sim- 
ulation was equal to the age at which aneurysm forma- 
tion began. Because aneurysms are thought to develop 
during early adulthood,11,20 the initial ages of individuals 
were drawn from a normal distribution, with a mean age 
of 25 ± 10 years (mean ± standard deviation) in Scenario 1. 
The variation in individual (constant) lesion growth rates 
was obtained using a Weibull probability distribution (see 
Appendix). We simulated a large number of shapes for 
this distribution given that the actual variation in individ-
ual lesion growth rates in the population was unknown. 
For each shape we calculated the IMGR, that is, the mean 
lesion growth rate over all individuals at the start of the 
simulation. Because episodes of SAH, on average, occur 
more often in persons with high lesion growth rates than 
in those with low rates, the mean aneurysm growth rate 
across alive individuals will decrease as time passes, that 
is, over the subsequent cycles. To account for the fact that 
the actual age at which aneurysm formation begins is un-
known, we tested the sensitivity of our results to changes 
in the initial age of individuals and the risk of rupture by 
defining various scenarios (Table 1). The risk of rupture 
in Scenarios 3 and 4 (Fig. 1 lower) was set to half that of 
Scenarios 1 and 2 (Fig. 1 upper).
Observational Data From the Literature Used to Analyze 
Simulation Output
We compared the outcomes in simulations with 
population-based data on SAH incidence rates, assum-
TABLE 1
Summary of transition probabilities used in the model
Parameter Value
overall 28-day case-fatality rate for SAH* 0.417
continuous relative risk of aneurysm rupture per mm 1.11 
of lesion diameter*














initial mean age of persons (yrs)§
in Scenarios 1 & 3 25 � 10
in Scenarios 2 & 4 35 � 10 
* Ingall et al., 2000.
† Juvela et al., 2000.
‡ Rinkel et al., 1998.
§ Minimum of 0.
H. Koffijberg et al.
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ing that the latter represented the true underlying process 
of aneurysm formation and rupture. In a multinational 
SAH epidemiological study, age-specific annual rates of 
SAH were given for 8 age categories, 25–29, 30–34, . . . , 
55–59, and 60–64 years, for 11 different populations.8 In 
a systematic review based on 5 autopsy and 5 angiogra-
phy studies, the prevalence of aneurysms in the age cat-
egories 20–39, 40–59, and 60–79 years was provided.20 
We combined these data and calculated the age-specific 
annual risk of aneurysm rupture (Table 3).
To assess the similarity between the incidence pat-
terns in the simulated cohorts and those in the actual 
population, we calculated the ratio of the incidence rate 
in the simulation and that in the actual population for the 
8 age categories shown in Table 3. For all scenarios the 
number of person-years simulated per age category was 
in the range of 0.25–3.00 times the actual number of per-
son-years reported in the literature. This finding ensures 
that the CIs in Fig. 2 are based on uncertainty for both the 
simulated and actual incidence rates.
Assessing the Correspondence Between Model Output and 
Actual Data
From a set of 2000 tested lesion growth rate distribu-
tions per scenario, we selected those that resulted in SAH 
incidence rates most closely resembling those observed in 
the population (see Appendix). Note that the best-fitting 
values for the initial mean lesion growth rates would ac-
curately approximate the incidence in some (the interme-
diate) age categories given that the specific goal of the op-
timization procedure was to find such values. Moreover, 
incidence rates in the intermediate age categories would 
be approximated more accurately than those in the lowest 
TABLE 2
Assumptions underlying the Markov model in this study
No. Description
1 every individual has exactly 1 aneurysm from the initial age of a person (when aneurysm size is assumed to be = 0 mm) to 
his or her age at death; the probability of additional aneurysm formation was omitted, although a lesion may not be con-
sidered an aneurysm if it is, for example, �2 mm in diameter; from the perspective of a growth process, all aneurysms 
start as 0-mm lesions; no conceptual distinction is made btwn lesions � or �2 mm
2 aneurysm size can only increase and never decrease; it is assumed that the max (theoretical) growth rate for any aneurysm is
10 mm/yr; it is also assumed that, in general, large growth rates occur less often than small growth rates
3 no risk factors for aneurysm rupture on a person level are taken into account; person sex might affect the risk of rupture in
some populations,* but this effect varies widely among populations;† other person characteristics such as genetic disposi-
tion or habits (for example, smoking) are not modeled explicitly, but different individual growth rates will account for
these characteristics implicitly
4 individuals w/ SAH either survive or die due to the SAH or subsequent treatment; patients who survive the episode are as-
sumed to have been treated for the ruptured aneurysm; these persons start the next month w/ an aneurysm size of 0 mm;
because of the constant growth rates w/in individuals, the aneurysm will always start growing again (at the same rate) af-
ter a period of 12 mos following lesion treatment
5 risk of aneurysm rupture is based on the risk for asymptomatic unruptured aneurysms in persons who have not had an SAH,
even though (see Assumption 4) some of the aneurysms in the model occurred in patients who had suffered an SAH &
survived, & therefore may have a higher risk of rupture
6 individuals w/ SAH can become disabled; however, the model does not differentiate btwn disabled & healthy individuals in
any way
7 probability of aneurysm rupture is a function of aneurysm size & location only; aneurysm shape is not taken into account; 
aneurysms �1 mm in diameter will not rupture; because aneurysms 2 mm in diameter have been known to rupture, a risk
of rupture was included for aneurysms �1 mm in diameter
8 total number of SAH incidents is calculated; no distinction is made btwn 1st & recurrent episodes of SAH
* From Juvela et al., 2001, and Rinkel et al., 1998.
† From Ingall et al., 2000.
Fig. 1. Line graphs showing the continuous function relat-
ing aneurysm size and location to the annual risk of rupture for 
Scenarios 1 and 2 (upper) and 3 and 4 (lower). The annual risk 
of rupture increases smoothly and exponentially with aneurysm 
size. It is highest for aneurysms in the VBS (VB) and lowest for 
those in the ACoA (ACA) and MCA.
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and highest age categories. A constant lesion growth rate 
that accurately approximated the SAH incidence rate for a 
certain age category would also probably approximate the 
incidence rates reasonably well for neighboring age catego-
ries but not for more distant ones. Thus, the best-fitting val-
ues for the initial mean lesion growth rates would approxi-
mate the incidence rates reasonably well for intermediate 
age categories but not for age categories at the extremes, 
which implies the best overall fit to the observed incidence 
rates. The incidence rates from the model and from the 
observational data were bound to be similar for some age 
categories given our optimization procedure; therefore, we 
defined the criterion for the hypothesis of constant aneu-
rysm growth to remain plausible, in one of our scenarios, 
as follows: all 95% CIs for the IDRs should include the 
value of 1 for all age categories simultaneously.
Results
Analysis of Simulation Output for Exemplary Growth 
Rate Distributions
Our results were based on the growth rate distribution 
TABLE 3
Number of person-years, SAH incidents, and aneurysm prevalence per age
category to determine the age-specific risk of rupture per person-year
No. Person-Years No. SAH Incidents Prevalence of Aneurysm Age-Specific Risk of Aneurysm
Age Category Per Age Category* Per Age Category* Per Age Category† Rupture Per Person-Year in % (95% CI)
25–29 6,383,137 168 0.0135 0.194 (0.167–0.226)
30–34 4,787,353 198 0.0135 0.307 (0.267–0.353)
35–39 4,787,353 296 0.0135 0.457 (0.408–0.513)
40–44 4,787,353 402 0.018 0.467 (0.424–0.515)
45–49 4,787,353 590 0.018 0.685 (0.632–0.743)
50–54 3,989,461 593 0.018 0.823 (0.762–0.895)
55–59 3,191,569 499 0.018 0.868 (0.795–0.948)
60–64 3,191,569 532 0.022 0.758 (0.697–0.826)
* Calculated from Ingall et al., 2000.
† Rinkel et al., 1998.
Fig. 2. Graphs depicting the IDRs for the SAH incidence rates for 8 age categories in the hypothetical cohort and 
the actual population together with their CIs. The IDRs for Scenarios 1 (A), 2 (B), 3 (C), and 4 (D) are shown. The 
horizontal line at IDR = 1 indicates the level at which the results from the simulation and the actual incidence agree 
perfectly.
H. Koffijberg et al.
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that led to SAH incidence rates most similar to those ob-
served in the population. As an illustration of the effects 
of different growth rate distributions on simulation out-
put, the simulation outputs for 4 different distributions of 
growth rates in Scenario 1 are shown in Fig. 3. The mean 
growth rates at the start of the simulation corresponding 
to these 4 distributions are 0.05, 0.15, 0.50, and 1.50 mm/
year. We depicted the absolute number of SAH incidents 
(Fig. 3A and B) and the annual risk of rupture (Fig. 3C and 
D). The solid black line in Fig. 3D represents the actual an-
nual risk of rupture for different age categories observed in 
the population (Table 3). In addition, Fig. 4 left depicts the 
average diameter of aneurysms at the time of rupture, and 
Fig. 4 right illustrates the average diameter of unruptured 
an eurysms. High initial mean lesion growth rates resulted 
in a large number of persons with fast-growing aneurysms 
and thus led to a large number of SAH incidents in the first 
3 decades of follow-up (Fig. 3A and C). Low IMGRs re-
sulted in a small number of SAH episodes. The number of 
SAH incidents, according to patient age, more or less fol-
lowed a gaussian distribution, with an increasing mean val-
ue as the IMGR decreased (Fig. 3B). The value of the IMGR 
also affected the average aneurysm size considerably. With 
an IMGR of 1.50 mm/year, almost all aneurysms ruptured 
within the first 2 decades of follow-up and had an average 
diameter of ~ 40 mm at that time (Fig. 4 left). This finding 
clearly was not corroborated by observations in the actual 
population. Figures 3 and 4 combined sug gest that values 
for the IMGR in the range of 0.15–0.50 mm/year most ac-
curately reproduced the SAH incidence rates observed in 
the population but with sizes of ruptured an eurysms much 
larger than those observed in clinical practice.
Analysis of Simulation Output
The IMGR that best fit actual observations was 0.18 
mm/year (see Appendix for the optimization method used). 
This initial rate resulted in SAH incidence rates in the sim-
ulated cohort that were closest to those in the actual popu-
lation. Corresponding IDRs are shown in Fig. 2A. Even 
with this best possible match, significant differences ap-
peared between the incidence rates obtained through simu-
lation and those observed in the population. The IDRs cal-
culated for Scenarios 2 (mean starting age 35 ± 10 years), 
3 (mean starting age 25 ± 10 years, 50% reduction in the 
risk of rupture compared with that in Scenario 1), and 4 
(mean starting age 35 ± 10 years, 50% reduction in the risk 
of rupture compared with that in Scenario 1) are shown 
in Fig. 2B–D. The corresponding best-fitting IMGRs were 
0.28 mm/year (Scenario 2), 0.26 mm/year (Scenario 3), 
and 0.37 mm/year (Scenario 4). Figure 2B–D indicates 
that the best-fitting value for the IMGR was sensitive to the 
initial age of individuals and to the risk of rupture. How-
ever, the different assumptions defined in Scenarios 2, 3, 
and 4 did not lead to a better match between results in the 
simulated model and those from the literature. There was 
no single IMGR that for each age category resulted in an 
incidence rate similar (that is, with overlapping 95% CIs) 
to that observed in the population. Figure 2 shows that in 
all scenarios there were statistically significant differences 
Fig. 3. Graphs depicting the number of SAH incidents during follow-up (A) and as function of patient age (B). 
Graphs illustrating the annual risk of rupture, on a logarithmic scale, during follow-up (C) and as a function of patient 
age (D), for 4 illustrative IMGRs. The solid black line in panel D represents the annual SAH incidence rates derived 
from the literature. FU = follow-up.
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between the incidence in the simulated cohort and that ob-
served in the population.
Discussion
We did not find a constant time-independent pattern 
of intracranial aneurysm growth that produced lesion 
incidence rates and sizes similar to those in the general 
population. It is therefore highly implausible that intracra-
nial aneurysms grow at a constant time-independent rate. 
On an individual level, periods of practically no growth 
can alternate with bursts of growth and high rupture risk. 
A period of growth can result in an episode of SAH or 
an enlarged but stable aneurysm. The periods without 
growth are probably long, because lesion growth is ob-
served in only 1 of 4 persons with an aneurysm over a 
mean follow-up period of 6.7 years.25
Our evidence for the implausibility of a constant an-
eurysm growth rate is based on a modeling approach and 
is therefore indirect. Empirical data on aneurysm growth 
rates from large, prospective follow-up studies are currently 
unavailable, and it is unlikely that such data will be collect-
ed in the near future, if ever. Frequent imaging in a large 
cohort of patients with unruptured aneurysms seems infea-
sible and unethical. Thus, in the area of aneurysm growth 
rates we must rely on anecdotal data and modeling stud-
ies. Although empirical data on intracranial aneurysms are 
hard to collect, the notion of irregular growth is supported 
by empirical data on abdominal aortic aneurysms.13
Two recent studies have been conducted using mathe-
matical modeling to validate the results of the International 
Study of Unruptured Intracranial Aneurysms.3,9,27,32 In one 
of these studies it was assumed that an aneurysm grows at 
a rate proportional to the cubic root function of the lesion 
age, which results in a faster than linear (that is, constant) 
growth rate.3 In the other study the authors made the ba-
sic assumption that aneurysms gain volume at a constant 
rate, implying that the growth rate in aneurysm diameter 
decreases exponentially as the diameter itself increases.32 
Although these studies remain open to considerable dis-
cussion,29 both demonstrated irregular growth rates. None-
theless, their outcomes diverge from observations made in 
clinical practice and population-based studies. In one study 
the model predicted much higher estimates than those 
observed in the general population for the prevalence of 
intracranial aneurysms, incidence of SAH, and mean age 
at the time of SAH.3 The other study lacked variability in 
aneurysm growth rates, which resulted in a risk of rupture 
that was independent of aneurysm size.32 Whether fully 
deterministic functions of irregular aneurysm growth can 
provide results that are corroborated by clinical evidence 
is currently unclear; aneurysm growth can also be chaotic 
and thus unpredictable.
Several features of aneurysm development were not 
incorporated into our model. First, the occurrence of mul-
tiple aneurysms was not accounted for. The International 
Study of Unruptured Intracranial Aneurysm investigators 
reported that 25% of persons without a previous SAH had 
multiple aneurysms, but this factor was not a statistically 
significant predictor of subsequent SAH.9 If rupture did oc-
cur in persons with multiple aneurysms it was usually the 
largest lesion that actually ruptured.11,28 In our model this 
lesion would be the first aneurysm to develop, which would 
determine the majority of rupture risk. Accordingly, we be-
lieve that given the goal of the current study this notion 
can be ignored. Second, in defining the probability of death 
after SAH or subsequent treatment, we did not include pa-
tient age as a determinant. The age-specific risks of rupture 
in Table 3 could only be determined up to the age of 64 
years. Nevertheless, although case fatality has been shown 
to differ across age groups 0–60 years and ≥ 61 years,9,19 
we suggest that the impact of ignoring the aging effects 
on outcome will remain marginal. After all, the majority 
of events occur at an age < 60 years. A third aspect that 
was intentionally ignored is the risk of aneurysm rupture 
related to lesion growth. Although aneurysm growth can 
directly increase the risk of rupture,1,10,17 no quantitative 
data on this relation are available; however, any risk as-
sociated with aneurysm growth in the model automatically 
would be constant within individuals (and varying between 
them). This additional risk of rupture would lead to lower 
best-fitting growth rates and cause all hypothetical aneu-
rysms to rupture (on average) earlier than in our present 
model. The decrease in the time to rupture would be high-
Fig. 4. Graphs showing for 4 illustrative IMGRs the average size of aneurysms at the time of rupture during 
follow-up (left) and the average aneurysm size as function of patient age (right). The peaks in the left panel for the 
high IMGRs are artifacts of the simulation model. For high mean growth rates almost all aneurysms rupture in the 
first 40 years of follow-up and too few rupture thereafter to provide a reliable estimate of the average size of ruptured 
aneurysms.
H. Koffijberg et al.
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est in individuals with high lesion growth rates, leading 
to higher incidence rates at low ages and lower incidence 
rates at high ages in the simulated cohort. Note, however, 
that the incidence in the first age category for the simulated 
cohort is already significantly higher than the correspond-
ing incidence in the observed population (Fig. 2). A fur-
ther increase in incidence for the low age categories would 
therefore yield incidence rates incompatible with observa-
tions from actual cohort studies.
A fourth phenomenon that has not been taken into 
account is the possibility of a spontaneous decrease in 
aneurysm size. Although decreases in size have been re-
ported,11 we did not include aneurysm shrinkage in our 
model, because structured data for a substantial number 
of persons were unavailable. Omission of this process 
may have influenced our results, although not greatly giv-
en the rarity of aneurysm shrinkage. In summary, these 4 
simplifications, used to keep our model comprehensible, 
are unlikely to have influenced the results considerably.
Risk factors for SAH, such as hypertension, smoking, 
and aneurysm shape, were not explicitly included in the 
model but were accounted for by the variation in growth 
rates between individuals in the population. Variation in 
growth rates leads directly to variation in aneurysm sizes 
between individuals and thus in variation in the risks of 
rupture between individuals. Persons with high growth 
rates, such as current smokers with hypertension, can 
thus be considered to have multiple risk factors, and indi-
viduals with low growth rates can be regarded as having 
no risk factors.
Conclusions
Our results show that a constant, time-independent 
growth rate of intracranial aneurysms is unlikely. Instead, 
growth is much more likely to be irregular and discontin-
uous, which leads to periods with and without growth and 
with high and low risks of rupture. The irregular growth 
of intracranial aneurysms has important implications for 
research, clinical practice, and screening effectiveness. In 
follow-up studies of unruptured aneurysms, the risks of 
rupture should be reported for the entire follow-up period; 
it is not rational to recalculate observed risks into yearly 
risks of rupture. As a consequence, for a particular patient 
with an unruptured aneurysm, data on the risk of rupture 
are known for only the relatively short periods of time 
that have been observed in follow-up studies; extrapolat-
ing remaining lifetime events from these risks is no more 
than guesswork. Screening of persons considered to have 
a risk of aneurysm growth and subsequent SAH, such as 
those with a family history, becomes increasingly less ef-
fective if the irregularity leads to the rapid development 
and rupture of aneurysms.23
Appendix
In this Appendix we discuss the details of the model, in particular, 
the calculations with respect to the risk of aneurysm rupture and the 
details of the distribution of growth rates in the model. Moreover, 
we explicate the iterative process by which the best-fitting growth 
rates (that is, the growth rates for which the hypothetical cohort most 
closely reproduced the incidence rates observed in the population) 
were determined. 
We used Mathematica (version 5.1, Wolfram Research, Inc.) to 
implement the model. In our model aneurysm growth rates were 
constant within a person but varied between individuals, and thus, 
the risk of SAH increased differently over time for each individual. 
This fact complicated the use of Poisson processes as a nonstation-
ary Poisson process must be defined for each individual to model 
episodes of SAH. A dynamic (micro)simulation was therefore pre-
ferred over a set of nonstationary Poisson processes, because the 
former requires only individual growth rates and a function for the 
risk of rupture based on aneurysm size, whereas the latter requires 
in dividual intensities for the risk of rupture and a function describing 
the manner in which these intensities should change over time.
The Model
The complete model is visualized in Fig. 5. In this figure qg,x is the 
probability of dying within the next time cycle at x years of age and 
of sex g.2 The function FProbSAH (s,l) represents the risk of rupture per 
time cycle as a function of aneurysm diameter s (in mm) and location 
l (where l є {ACoA, MCA, ICA, VBS}; see Fig. 1). For the overall 
28-day case fatality rate for SAH and subsequent treatment, 0.417 
was used,8 and all survivors were assumed to have had successfully 
oblit erated aneurysms. Aneurysm growth occurs every cycle in all 
in dividuals, except in persons with recently obliterated aneurysms, 
who have FTreated set to 1 for the 1st year after an SAH episode (see 
As sumption 4 in Table 2). All points in time and differences over 
time (for example, age) are measured in months. Because aneurysms 
can exhibit fast growth in a short period of time,15,28 we used time 
cy cles of 1 month in our simulation; thus, we were able to accurately 
de termine the time of rupture and the aneurysm size at that time, 
even for fast-growing aneurysms. The simulation stopped when all 
in dividuals from the hypothetical cohort had died.
Annual Risk of Aneurysm Rupture
To determine the annual risk of aneurysm rupture we used the 
estimates from Table 1. Given the continuous relative risk of rupture 
per mm increase in diameter and an appropriate midpoint of 1 of 
the size intervals 2–6, 7–9, or 10–26 mm, it is possible to define a 
function that calculates the annual risk of rupture for a given aneu-
rysm size. Using these 3 intervals, their midpoints of 4, 8, and 14 
mm, and the continuous relative risk of rupture of 1.11 per mm, 3 
exponential functions could be defined for this risk: F1 through the 
point represented by aneurysm size 4 mm and risk of rupture 0.011 
(x and y, respectively), F2 through the point described as aneurysm 
size 8 mm and risk of rupture 0.023, and F3 through the point rep-
resented by aneurysm size 14 mm and risk of rupture 0.028. Note 
that for the size interval 10–26 mm, the midpoint or average value 
of 14 mm was used, instead of 18 mm, because larger aneurysms 
are more rare than smaller ones. Only a single function for the risk 
of rupture is required; therefore, we defined the function FAVG as 
the average of F1, F2, and F3. To comply with Assumption 7 (Table 
2)—that is, aneurysms smaller than 1 mm will not rupture—we set 
FAVG to 0 for aneurysms of size s, so that 0 ≤ s < 1 mm. Finally, to 
ensure that the annual risk of rupture rose smoothly from 0 at s = 1 
mm, an additional alteration was made to FAVG: for aneurysms of size 
s, where 1 ≤ s < 4 mm, the value of FAVG is multiplied by the factor 
(1/3(s − 1))1/3. The function FAVG can be related to the diameter-cube 
hypothesis;5 that is, the annual rupture risk of an aneurysm varies as 
the 3rd power of its diameter D, so that rupture risk = kD3, where k is 
a constant. We calculated that for the aneurysm sizes 10–30 mm, the 
FAVG closely resembles kD2.5. For aneurysm diameters 1–10 mm, the 
FAVG still represents a small risk of rupture, whereas kD3 decreases to 
0 very quickly with decreasing aneurysm diameter.
From Table 1 a hypothetical average rate of rupture for the 4 
cited locations can be computed (1.95/100 person-years). Given the 
lo cation l of an aneurysm, where l є {ACoA, MCA, ICA, VBS}, 
we denote the relative risk of rupture for that location by RRl, with 
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RRACoA ≈ 0.564, RRMCA ≈ 0.564, RRICA ≈ 0.615, and RRVBS ≈ 2.256. 
Now the function FProbSAH(s,l) for an aneurysm of diameter s mm and 
location l is defined as follows: FProbSAH (s,l) = RRl ×  FAVG(s).
This function is continuous and strictly increasing for s > 1 mm. 
Furthermore, it is smooth; that is, there are no thresholds at which the 
risk of rupture changes abruptly (there is no 10-mm barrier).9,17
Distribution of Aneurysm Growth Rates
No information on the distribution of growth rates for individuals 
is available from the literature for reasons outlined above. From the 
ASTRA study we know that in a group of 610 individuals who had 
recovered completely from a previous SAH and undergone aneu-
rysm clipping or coiling, aneurysm growth occurred in 25% (mean 
follow-up period 6.7 years).25 In this study, growth was detected if 
an aneurysm had grown (on average) at least 0.5 mm in 7 years, that 
is, ~ 0.075 mm/year. Any aneurysm growth on average < 0.075 mm/
year would not have been detected on CT angiography. Because 
it seems that in the majority of individuals with aneurysms these 
lesions do not grow and because it is known that in the minority of 
people with growing aneurysms the growth rates can be substantial 
(for example, surpassing 2 mm/year), different distributions of con-
stant growth rates were defined for individuals who do and do not 
have noticeable aneurysm growth.
Growth Rate Distribution for Aneurysms Without Noticeable 
Growth
Within the model, aneurysms do not grow noticeably if their 
growth (if any) cannot be measured, that is, if they grow < 0.075 
mm/year on average, as was the case in 75% of the participants in 
the ASTRA study. For an individual with an aneurysm that does 
not exhibit measurable growth, the actual growth rate is determined 
by drawing a random growth rate value from a uniform distribution 
with a minimum 0 mm/year and a maximum 0.075 mm/year. In the 
aforementioned 75% of participants, however, the actual aneurysm 
growth rate would be so small (on average 0.0375 mm/year) that the 
lesions probably would not reach even 1 mm in diameter, the size 
below which aneurysms cannot rupture in the model.
Growth Rate Distribution for Aneurysms With Noticeable Growth 
Aneurysms that noticeably grow have an average growth rate of > 
0.075 mm/year. For persons with these specific aneurysms a Weibull 
distribution was defined, depending on a shape parameter α and a 
scale parameter β, which represented the distribution of possible 
growth rates. The parameter β is a pure number (that is, it is dimen-
sionless) known as the “Weibull slope” because its value is equal 
to the slope of the regressed line in a probability plot. The values 
of the parameters α and β defining the Weibull distribution cannot 
be assigned any medical interpretation. The main reason for using a 
Wei bull distribution is the flexibility with respect to the shapes this 
distribution can take on for different combinations of (α, β). Note 
that according to Assumption 2 in Table 2 all growth rates should fall 
in the range of 0–10 mm/year, and the probability density function of 
the distribution of growth rates should (approximately) be decreas-
ing over this range. The right tail of the Weibull distribution may be 
infinite for some combinations of (α, β); therefore, any growth rates 
randomly drawn from the distribution that are > 10 mm/year are 
rejected, and new random values are drawn until a valid growth rate 
is determined. This rejection process effectively increases the prob-
abilities of growth rates in the range of 0–10 mm/year to an extent 
proportional to the value of these probabilities. The result of this 
pro cess is a distribution that has the same shape in the range 0–10 
mm/year as the Weibull distribution. Given that the shape of the 
distribution of individual growth rates (that is, the form or appear-
ance of the probability distribution curve) is unknown, a large set 
of (α, β) values was used, representing different shapes, to evaluate 
the scenarios. To define the shape of the Weibull distribution, α and 
β values remained in the range of 0–50. For an individual with an 
an eurysm that exhibited measurable growth, the actual growth rate 
of that lesion was determined by drawing a valid growth rate value 
from the Weibull distribution and adding to it the minimum measur-
able growth rate of 0.075 mm/year.
Determining the Aneurysm Growth Rate for Individuals
Each individual has a 75% chance of belonging to the group of 
per sons without measurable growth and a 25% chance of belong-
ing to the group with measurable growth. For all persons in the 
sim ulation an individual growth rate was determined as follows: a 
random drawing process indicated to which of the 2 groups a person 
belonged, and thereafter the aneurysm growth rate for an individual 
was determined using either the uniform distribution or the Weibull 
distribution, as described above.
Growth Rate Characteristics of the Hypothetical Cohort
After determining all the individual aneurysm growth rates, it is 
possible to calculate, for example, the mean and median growth rate 
for the hypothetical cohort. Note that the mean value of all individual 
growth rates is to be interpreted as the IMGR, that is, the mean growth 
rate at the start of, not throughout, the simulation process. Once the 
simulation process starts, individuals with high lesion growth rates 
Fig. 5. Schematic showing the Markov model for the hypothetical cohort of patients. The transition probability qg,x denotes the mortality quotient for an individual of sex g and age x, FTreated indicates whether or not a particular person was treated after surviving an episode of SAH in the last 12 cycles (months), and FProbSAH(s,l) denotes the risk of rup-ture of an aneurysm of size s mm at location l.
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will have higher chances of dying each month (due to a higher risk 
of SAH) than those with a near-zero growth rate, which causes the 
mean growth rate to decline with time. The values used for (α, β) lead 
to IMGR values in the range of 0–2.5 mm/year. Although an IMGR 
of > 2 mm/year may seem high, remember that for all combinations 
of (α, β) 75% of all persons have a growth rate < 0.075 mm/year. 
High IMGRs are therefore caused by a small number of individuals 
with very high lesion growth rates (for example, on the order of 5–10 
mm/year) and not by a large number of individuals with fairly high 
growth rates (for example, on the order of 0.5–2 mm/year).
Determining the Best-Fitting Growth Rate Distribution
The different shapes the unknown growth rate distribution can 
take were defined by a set of values for (α, β), with both α and β 
in the range 0–50. For a specific value of (α, β) the age-specific 
SAH incidence rates in the hypothetical cohort were compared with 
actual incidence rates in the population from the literature (Table 
3). To assess the difference or error between this simulation output 
and observed incidence rates, the IDR (that is, the ratio of incidence 
rates) was calculated for the 8 age categories 25–29, 30–34, . . . , 
55–59, and 60–64 years. Calculation of the IDR and its 95% CI was 
based on the number of SAH incidents observed and the number of 
person-years in which these incidents were observed.7 The error for 
the model, given some value for (α, β), was defined as follows:
By definition Errα,β has a value ≥ 0 for all values of (α, β), with 
values close to 0 indicating little discrepancy between the incidence 
rates in the hypothetical cohort and those in the population from the 
literature and large values indicating a substantial mismatch. We 
determined the best-fitting shape of the growth rate distribution, that 
is, the (α, β) value for which Errα,β has the lowest value, for each of 
the 4 scenarios in 2 steps. Step 1: A set of 1000 random values for 
(α, β) was constructed, with α and β in the given range. For each 
value of (α, β), the model was simulated and the value of Errα,β was 
calculated. From the 20 smallest values for Errα,β, a range of values 
for the IMGR was derived for which simulation output was clos-
est to the observed incidence rates. For Scenario 1, this range was 
determined to be 0.13–0.24 mm/year. Step 2: A new set of 1000 
random values for (α, β) was constructed for which the IMGR value 
corresponding to each (α, β) combination had to fall in the IMGR 
range determined in Step 1. For each value of (α, β) the model was 
simulated, and the value of Errα,β was calculated again. The values 
calculated for (α, β) leading to the smallest value of Errα,β were 
accepted as the best-fitting values for (α, β). The IDRs correspond-
ing to the best-fitting value of (α, β) were calculated.
For Scenario 1 the best-fitting value for (α, β) was found to be 
(20.92, 0.54), and the IDRs calculated for the 8 age categories 25–25, 
30–34, . . . , 55–59, and 60–64 years were equal to 1.29, 1.14, 0.93, 
1.05, 0.88, 0.82, 0.91, and 1.12, respectively. The set of IDRs for 
all 4 scenarios together with their 95% CIs is depicted in Fig. 2. For 
all scenarios the number of person-years simulated per age category 
was in the range of 0.25–3.00 times the number of person-years per 
age category in the literature (Table 3). This result ensures that the 
CIs for the IDRs were based on the uncertainty in both the simula-
tion output and the incidence rates observed in the population. The 
number of individuals in the simulation could be increased to cal-
culate even smaller CIs, based almost completely on the uncertainty 
surrounding the observed incidence rates. However, simulating more 
individuals would not lead to different results because the CIs for 
the IDRs obtained using a simulation of 50,000 individuals already 
failed to encompass the value of 1 in several age categories, for all 
scen arios.
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